secwatch.observer — SEC 8-K summary
======================================

Issuer:     Atea Pharmaceuticals, Inc. (AVIR)
CIK:        0001593899
Form:       8-K
Filed at:   2023-06-21T23:59:59+00:00
Accession:  0001193125-23-171257
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Atea Pharmaceuticals amends bylaws and reports annual meeting voting results
----------------------------------------------------------------------------

- Bylaws amended to adopt universal proxy rules and enhance stockholder nomination disclosure.
- Directors Jerome Adams and Barbara Duncan elected with 34.5M and 40.6M votes for, respectively.
- Advisory vote on executive compensation approved with 40M for (70% of votes cast).
- Ratification of KPMG as auditor approved with 64.5M for, 6.3M against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1593899/000119312523171257/0001193125-23-171257-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1593899/000119312523171257/d467534d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-171257

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer